back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-06-27 09:25 Tx date 2025-06-24 |
$LABS
MediPharm Labs Corp. |
Halyk, Christopher John
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+82,980 vol |
347,710 | |
| Filed 2025-06-27 09:23 Tx date 2025-06-24 |
$LABS
MediPharm Labs Corp. |
Halyk, Christopher John
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-178,570 vol |
178,572 | |
| Filed 2025-06-25 15:29 Tx date 2025-06-20 |
$LABS
MediPharm Labs Corp. |
Halyk, Christopher John
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+178,571 vol |
357,142 | |
| Filed 2024-12-24 10:23 Tx date 2024-12-20 |
$LABS
MediPharm Labs Corp. |
Halyk, Christopher John
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+178,571 vol |
178,571 | |
| Filed 2024-12-13 11:10 Tx date 2024-12-09 |
$LABS
MediPharm Labs Corp. |
Halyk, Christopher John
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+89,365 vol |
264,730 | |
| Filed 2024-12-13 11:09 Tx date 2024-12-09 |
$LABS
MediPharm Labs Corp. |
Halyk, Christopher John
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-192,307 vol |
0 | |
| Filed 2024-06-28 12:52 Tx date 2024-06-24 |
$LABS
MediPharm Labs Corp. |
Halyk, Christopher John
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+89,365 vol |
175,365 | |
| Filed 2024-06-28 12:51 Tx date 2024-06-24 |
$LABS
MediPharm Labs Corp. |
Halyk, Christopher John
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-192,308 vol |
192,307 | |
| Filed 2023-12-27 19:41 Tx date 2023-12-22 |
$LABS
MediPharm Labs Corp. |
Halyk, Christopher John
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+384,615 vol |
384,615 | |
| Filed 2023-12-27 19:40 Tx date 2020-08-04 |
$LABS
MediPharm Labs Corp. |
Halyk, Christopher John
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-03-12 11:59 Tx date 2023-03-05 |
$LABS
MediPharm Labs Corp. |
Halyk, Christopher John
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-86,000 vol |
0 | |
| Filed 2021-03-08 15:32 Tx date 2021-03-05 |
$LABS
MediPharm Labs Corp. |
Halyk, Christopher John
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$60,199
+86,000 vol $0.70 each |
86,000 | |
| Filed 2021-03-08 15:31 Tx date 2020-08-04 |
$LABS
MediPharm Labs Corp. |
Halyk, Christopher John
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-08 15:31 Tx date 2021-03-05 |
$LABS
MediPharm Labs Corp. |
Halyk, Christopher John
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$49,880
+86,000 vol $0.58 each |
86,000 | |
| Filed 2021-03-08 15:30 Tx date 2020-08-04 |
$LABS
MediPharm Labs Corp. |
Halyk, Christopher John
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-08-05 15:40 Tx date 2020-08-04 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Halyk, Christopher John
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
300,000 |